Bioorganic and Medicinal Chemistry Letters p. 5599 - 5603 (2004)
Update date:2022-08-03
Topics:
DeVita, Robert J.
Parikh, Mamta
Jiang, Jinlong
Fair, Jason A.
Young, Jonathan R.
Walsh, Thomas F.
Goulet, Mark T.
Lo, Jane-L.
Ren, Ning
Yudkovitz, Joel B.
Cui, Jisong
Yang, Yi T.
Cheng, Kang
Rohrer, Susan P.
Wyvratt, Matthew J.
Potent neutral replacements of the basic amine at the 4-position of quinolone non-peptide GnRH antagonists are reported. A series of neutral, nonbasic quinolone GnRH antagonists were prepared via Mitsunobu alkylation of protected and unprotected 4-hydroxy quinolone intermediates. The synthetic route was improved by utilization of unique reactivity and convergency afforded by the use of mono and bis-trimethylsilylethyl protected quinolones. Potent neutral GnRH antagonists were identified, including ether and lactam derivatives, that show similar in vitro binding affinity and functional activity as compared to the earlier basic 4-aminoalkyl quinolone series of nonpeptide GnRH antagonists.
View Morewebsite:http://www.oceanchem-group.com
Contact:86-536-8596048
Address:9th floor,Building B future Plaza, No.88.Fenghuang Street,Weifang,Shandong,China
Nanjing Zelang Medical Technology Co. Ltd
Contact:86-25-83063290/13770714480
Address:Ganjiabian 108# 01 Unit,701-702 room,Yao Hua Street,Qixia District,Nanjing,Jiangsu,China
Contact:+86-13914766747
Address:Floors 21&22, Jin Cheng Tower, No. 216 Middle Longpan Road, Nanjing
website:http://www.greenutra.cn
Contact:0086-411-39553357
Address:No. 7-1-1802, Huizhi Garden,Ocean Square,Dalian, 116033, China
website:https://www.bocsci.com/
Contact:1-631-485-4226
Address:Ramsey Road
Doi:10.1248/cpb.52.1114
(2004)Doi:10.1039/jr9350000258
(1935)Doi:10.1021/acs.orglett.5b01612
(2015)Doi:10.1007/BF00761612
(1982)Doi:10.1016/S0040-4039(01)82999-3
(1981)Doi:10.1002/jps.2600710210
(1982)